Researchers is substantially improved the development of a innovative treatment for ATTR-CM, employing Attruby. Early patient data suggests potential outcomes for those affected from the severe disease. This effort highlights researchers’ commitment to treating significant medical requirements in the heart disease field. Attruby: BridgeBio's Nov